Serotonin Uptake InhibitorsFluoxetineCitalopramParoxetineFluvoxamineAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicAntidepressive AgentsSertralineSerotoninSerotonin Plasma Membrane Transport ProteinsCyclohexanolsSerotonin SyndromeDepressive DisorderDepressive Disorder, MajorAdrenergic Uptake InhibitorsReceptor, Serotonin, 5-HT1AReceptors, Serotonin, 5-HT1Receptors, SerotoninLofepramineDepressionSerotonin AntagonistsDothiepinAlzheimer DiseaseClomipramineDesipramineObsessive-Compulsive DisorderPremenstrual Syndrome1-NaphthylamineSerotonin Receptor AgonistsSerotonin 5-HT1 Receptor AntagonistsReceptor, Serotonin, 5-HT2ASerotonergic NeuronsAnti-Anxiety Agents8-Hydroxy-2-(di-n-propylamino)tetralinToxicity Tests, SubacuteReceptor, Serotonin, 5-HT1BRaphe NucleiNeurotransmitter Uptake InhibitorsSerotonin 5-HT2 Receptor AntagonistsBehavior, AnimalSerotonin 5-HT4 Receptor AgonistsAnxiety DisordersDrug InteractionsSuicideDepressive Disorder, Treatment-ResistantPsychiatric Status Rating ScalesMonoamine Oxidase InhibitorsTreatment OutcomeCognitive TherapyMianserinReceptors, Serotonin, 5-HT2Serotonin AgentsFenfluraminePregnancy ComplicationsDouble-Blind MethodSexual Dysfunction, PhysiologicalAnxietySwimmingTryptophan HydroxylaseNorepinephrine Plasma Membrane Transport ProteinsNortriptylineDose-Response Relationship, DrugMoclobemideDroxidopaBrainPanic DisorderMicrodialysisAmitriptylinePatient Dropouts5,7-DihydroxytryptamineAntipsychotic AgentsRandomized Controlled Trials as TopicPsychotherapyAutoreceptorsPiperazinesPsychotropic DrugsRats, Sprague-DawleyImmobility Response, TonicCytochrome P-450 CYP2D6AlprazolamImipramine5-HydroxytryptophanDrug Utilization ReviewPhenelzineAnalysis of VarianceSerotonin 5-HT1 Receptor AgonistsBupropionHindlimb SuspensionPlacebosMotor ActivityEjaculationDrug CostsTime FactorsThiophenesBenzodiazepinesMembrane Transport ProteinsMaprotilineDrug OverdosePrenatal Exposure Delayed Effects